Groupe Renault - 2020 Universal Registration Document

147 GROUPE RENAULT I UNIVERSAL REGISTRATION DOCUMENT 2020 02 CREATING SHARED VALUES THAT RESPECT SOCIETY AND THE ENVIRONMENT GROUPE RENAULT GROUPE RENAULT: A COMPANY THAT ACTS RESPONSIBLY CORPORATE GOVERNANCE FINANCIAL STATEMENTS RENAULT AND ITS SHAREHOLDERS ANNUAL GENERAL MEETING OF RENAULT ON APRIL 23, 2021 ADDITIONAL INFORMATION Initiatives for caregivers Numerous loans of vehicles were arranged to make it as easy as possible for front-line health workers to fight the epidemic. In France , Groupe Renault made nearly 1,300 vehicles available to such employees at the end of March, including 300 Renault ZOE vehicles from the ZITY car-sharing service in Paris. In Switzerland , the dealer network made around 100 Renault ZOE vehicles available to several emergency organizations (Red Cross, Spitex and Pro-Senectute). In Romania , around 100 Dacia or Renault vehicles were entrusted to the Ministry of Health for hospital staff. In Morocco , 50 LODGY, TRAFIC and MASTER vehicles were specially converted into ambulances to transport patients. In addition, the Renault Morocco Foundation donated 100 laptops to the Melloussa for Local Development association to support the schooling of young people in disadvantaged areas. Renault Algérie also lent vehicles to hospitals in Oran and Boufarik and to the health departments in Algiers and Bilda, while the Oran plant manufactured respirator valves and oxygen fittings for the city hospital. In Mexico , a joint initiative between Renault, Nissan and Mitsubishi involved the loan of 25 vehicles to international NGO Doctors Without Borders. In Colombia , Groupe Renault joined forces with local associations to transport food products using the KANGOO Z.E. to underprivileged families and health workers. In other countries, the Group's partner car-sharing services offered their fleets to the medical profession: this was the case in Denmark, with the loan of 400 electric vehicles from the Green Mobility service. In March, several industrial sites in France, but also in Spain, Portugal and Slovenia, donated around 120,000 masks (from plant stocks originally intended for maintenance operations) to health workers . Meanwhile, in Russia, AVTOVAZ donated 6,800 protective suits to hospitals in Togliatti. And in France, the Flins site offered 300 suits usually used for painting to the teams at the Mignot Hospital in Versailles, the main intensive care facility in western Paris. Remarkable solidarity initiatives launched, notably in engineering In Spain , 120 Groupe Renault employees created the Renault al Rescate (Renault to the rescue) movement, which formed a genuine chain of solidarity that began making masks using 3D printers. In just four days, more than 4,000 of them were distributed to hospitals and retirement homes in Valladolid, Palencia, Malaga and Jerez. A similar initiative was also launched by Renault teams in Brazil. In Turkey, Oyak Renault produced protective equipment for health workers at the Bursa plant in collaboration with the provincial health department, including intubation equipment, fever measurement units and mobile sampling and testing booths. A large number of individual employees undertook to make items including visors, masks, hand sanitizer dispensers, overshirts and door pullers, or to staff telephone hotlines or provide other services. In France , many centers and plants (Douai, Sovab, CRP, Cléon, Flins, Le Mans, Villeurbanne, Dieppe, MCA) decided to manufacture visors from injection molds developed at the Technocentre, producing several thousand units per week. This experience was shared through dedicated task forces with Renault teams in Romania, Brazil and the Africa – Middle-East – India region so that such initiatives could be swiftly replicated locally. Thanks to its employees, Groupe Renault manufactured 30,000 visors in the first week . In France, Groupe Renault joined forces with other companies in "Makers for Life", an initiative led by the CEA and supported by the French Government Defense procurement and technology agency and the Ministry of Defense's Defense Innovation Agency, to design a low-cost, emergency respirator for series production. In this context, a team of Renault and Renault Sport Racing engineers designed several parts specifically for the project, in particular the blower , an engine component that supplies the respirator with compressed air. These engineers also developed a virtual digital lung model that allows the physical and software design of the ventilator to evolve rapidly by simulating a range of clinical cases. The Group's exceptional network of many skills – notably mechanical, electrical and electronic engineering, product-process design, manufacturing and logistics, Renault medical experts, quality, purchasing, industrial property and management control – was a determining factor in optimizing the design of the ventilator and making it compatible with large-scale production. Some 15 artificial respirator prototypes were manufactured at the Prototype production center at the Technocentre in Guyancourt. The developments of the MAKAIR RE20 ventilator specific to Renault (including the 11 patents filed) were made available under a free open-source license , via the Github open-source platform, to enable players in crisis situations to manufacture this model of artificial respirator cheaply. Similar projects also emerged in Spain and Romania. Most often collective, they demonstrate the importance of complementary know-how and the value of open-source data sharing. The health crisis has also led to a shortage of syringe pumps that can continuously administer an average of four medications per patient. To help fill the gap in intensive care units, a team hailing mainly from the engineering and design departments and working at the Guyancourt, Aubevoye and Nice sites worked with the hospitals of Bichat-Claude Bernard, La Pitié-Salpêtrière and the Paris public hospital system (AP-HP) to produce a prototype electric syringe pump and studies for the series production, validation and approval of the product by the medical authorities. It was a feat achieved in record time and hailed by the AP-HP's General agency for health equipment and products (AGEPS). Here too, all plans and software were made available free of charge to the scientific community via the Github open-source platform.